Key terms
About PHR
Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PHR news
Apr 21
9:43am ET
Phreesia (NYSE:PHR): A Value Play in Healthcare Tech
Apr 11
4:55am ET
Phreesia management to meet with KeyBanc
Apr 10
4:06pm ET
Phreesia management to meet with KeyBanc
Apr 09
7:36am ET
Truist Financial Reaffirms Their Buy Rating on Phreesia (PHR)
Apr 05
6:47am ET
Piper Sandler Sticks to Their Buy Rating for Phreesia (PHR)
Mar 21
7:10am ET
Analysts Offer Insights on Healthcare Companies: Phreesia (PHR) and OmniAb (OABI)
Mar 21
6:07am ET
Phreesia price target raised to $30 from $28 at JMP Securities
Mar 21
3:45am ET
Phreesia (PHR) Gets a Buy from JMP Securities
Mar 19
12:07pm ET
Phreesia management to meet virtually with DA Davidson
Mar 19
6:52am ET
Phreesia names Jack Callahan as new Chief Technology Officer
Mar 19
4:55am ET
Phreesia management to meet with JMP Securities
Mar 18
12:51pm ET
Phreesia management to meet with JMP Securities
Mar 18
7:14am ET
Phreesia price target raised to $31 from $30 at Baird
Mar 17
2:01am ET
Phreesia’s Indian Expansion: Navigating Risks in a Dynamic Market
Mar 15
9:42am ET
Phreesia price target raised to $23 from $17 at RBC Capital
Mar 15
7:20am ET
Phreesia price target raised to $37 from $36 at Canaccord
Mar 14
4:04pm ET
Phreesia backs FY25 revenue view $424M-$434M, consensus $428.12M
Mar 14
4:04pm ET
Phreesia reports Q4 EPS (56c), consensus (26c)
Mar 13
3:55am ET
KeyBanc Sticks to Their Buy Rating for Phreesia (PHR)
Mar 12
8:38am ET
Truist Financial Sticks to Its Buy Rating for Phreesia (PHR)
Mar 12
12:55am ET
Phreesia (PHR) Receives a Buy from JMP Securities
Mar 07
4:46am ET
Barclays Sticks to Their Buy Rating for Phreesia (PHR)
Feb 26
6:17am ET
Buy Rating Affirmed for Phreesia on Strong Growth and Market Expansion Potential
Feb 26
6:05am ET
Phreesia initiated with a Buy at Truist
Jan 22
1:50pm ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), RegenXBio (RGNX) and ESSA Pharma (EPIX)
No recent press releases are available for PHR
PHR Financials
Key terms
Ad Feedback
PHR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PHR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range